Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CBD for Inflammation in People Living With HIV
NCT05209867Phase 4Completed
- Sponsor
- University of Florida
- Start
- May 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cannabidiol in chronic inflammation, sponsored by University of Florida. Started May 2022; status: completed.
02
Drugs
cannabidiol
03
Conditions
chronic inflammation
Beyond the preview
Go deeper on NCT05209867.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05209867.